Published in J Exp Med on November 01, 1984
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics (2007) 1.55
Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Am Ophthalmol Soc (1990) 1.47
Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest (1988) 1.26
Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem (2011) 1.16
Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A (1998) 1.07
The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci U S A (1991) 1.05
The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice. Exp Biol Med (Maywood) (2010) 0.93
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol (2014) 0.93
Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J Neurol Sci (2009) 0.91
Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J Exp Med (2003) 0.89
Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects. Br Med J (Clin Res Ed) (1985) 0.88
Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke. Free Radic Biol Med (2013) 0.87
Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. Immunology (1991) 0.87
Iron chelation and multiple sclerosis. ASN Neuro (2014) 0.84
The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis. Clin Exp Immunol (2004) 0.81
In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation. J Neurosci Res (2013) 0.77
Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett (1978) 5.12
Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol (1981) 3.15
THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM. Ann N Y Acad Sci (1964) 2.02
Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet (1972) 2.01
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95
The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol (1981) 1.79
Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med (1982) 1.75
Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. Fed Proc (1976) 1.62
Production of superoxide, hydrogen peroxide and hydroxyl radicals by phagocytic cells: a cause of chronic inflammatory disease? Cell Biol Int Rep (1982) 1.57
Long-term desferrioxamine therapy in thalassemia. Ann N Y Acad Sci (1974) 1.56
Immunopathology of demyelination in autoimmune diseases and virus infections. Br Med Bull (1977) 1.52
Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity. J Immunol (1982) 1.49
Storage iron kinetics. VII. A biologic model for reticuloendothelial iron transport. J Clin Invest (1974) 1.38
Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol (1979) 1.25
Iron: its intracellular localization and possible role in cell division. Proc Natl Acad Sci U S A (1970) 1.20
Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions. J Immunol (1982) 1.19
Homing of Lyt-2+ and Lyt-2- T cell subsets and B lymphocytes to the central nervous system of mice with acute experimental allergic encephalomyelitis. J Immunol (1984) 1.03
Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis. Clin Exp Immunol (1973) 0.99
Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol (1966) 0.96
Treatment of dialysis osteomalacia with desferrioxamine. Lancet (1982) 0.91
Iron storage, IV. Cellular distribution of excess liver iron. Am J Pathol (1962) 0.89
The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines. J Immunol (1983) 0.88
Lymphoid cell positioning: a new proposal for the mechanism of control of lymphoid cell migration. Symp Soc Exp Biol (1978) 0.87
Transfer of murine experimental autoimmune encephalomyelitis and cell-mediated immunity to myelin protein is effected by Lyt-1 cells. J Neuroimmunol (1983) 0.82
Acute experimental autoimmune encephalomyelitis: T- and B-cell distribution within the target organ. Cell Immunol (1982) 0.82
Mineral composition of brains of normal and multiple sclerosis victims. Proc Soc Exp Biol Med (1980) 0.80
Formation of malonaldehyde and focal brain edema induced by subpial injection of FeCl2 into rat isocortex. Brain Res (1982) 0.79
Adoptive transfer of experimental allergic encephalomyelitis: requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic protein. Cell Immunol (1981) 0.78
Immunopathology of allergic encephalomyelitis. Prog Clin Biol Res (1980) 0.78
MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol (1979) 15.58
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (1974) 13.24
Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev (1976) 8.10
Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature (1974) 6.99
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature (1996) 6.17
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med (1996) 6.08
Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity (1998) 5.98
Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (1994) 5.49
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature (1996) 5.45
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med (1977) 5.20
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol (2001) 4.98
Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol (1990) 4.83
T-cell-mediated immunopathology in viral infections. Transplant Rev (1974) 4.72
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med (1991) 4.49
Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature (1975) 4.41
H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med (1975) 4.16
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol (1997) 4.10
Possible importance of macrophage-derived mediators in acute malaria. Infect Immun (1981) 3.58
Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 3.51
Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature (1975) 3.49
A biological role for the major histocompatibility antigens. Lancet (1975) 3.40
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol (1992) 3.31
Defective lymphoid development in mice lacking Jak3. Science (1995) 3.04
Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. Proc Natl Acad Sci U S A (1977) 3.02
Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01
A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J Virol (2000) 2.79
Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun (1983) 2.59
Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature (1974) 2.55
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med (1978) 2.54
The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (1994) 2.53
Characteristics of the interaction in vitro between cytotoxic thymus-derived lymphocytes and target monolayers infected with lymphocytic choriomeningitis virus. Scand J Immunol (1974) 2.42
Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity (1994) 2.39
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A (2000) 2.38
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J Gen Virol (1991) 2.33
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology (1977) 2.28
Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol (1974) 2.23
Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells. J Exp Med (1990) 2.21
Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. J Immunol (1995) 2.20
Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses. J Exp Med (1977) 2.16
Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun (1991) 2.16
Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J Immunol (2001) 2.14
CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A (1999) 2.14
Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg (1996) 2.13
Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. J Immunol (1993) 2.07
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol (1994) 2.07
Major transplantation antigens, viruses, and specificity of surveillance T cells. Contemp Top Immunobiol (1977) 2.05
IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol (1999) 2.05
Recruitment and proliferation of CD8+ T cells in respiratory virus infections. J Immunol (1995) 2.05
A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today (1993) 2.02
Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. J Immunol (1995) 2.01
Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol (1999) 2.00
Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J Exp Med (1993) 1.98
Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex. J Immunol (1975) 1.93
Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet (1978) 1.91
Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med (1997) 1.88
Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J Virol (1998) 1.87
Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice. J Virol (2000) 1.87
In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells. Proc Natl Acad Sci U S A (1999) 1.87
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature (1998) 1.87
The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J Immunol (2001) 1.85
Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J Virol (2000) 1.85
Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol (1998) 1.82
Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes. Immunology (1976) 1.81
Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis. J Exp Med (1973) 1.80
A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A (1999) 1.78
Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol (1976) 1.78
The discovery of MHC restriction. Immunol Today (1997) 1.76
Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J Immunol (1996) 1.75
Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci U S A (1998) 1.73
Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol (1999) 1.71
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol (1990) 1.67
CD40 ligand has potent antiviral activity. Nat Med (1995) 1.64
Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol (2000) 1.64
In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A (1977) 1.63
Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res (1984) 1.62
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
Protection against a lethal avian influenza A virus in a mammalian system. J Virol (1999) 1.60
Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol (1986) 1.58
Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. Reg Immunol (1993) 1.56
Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med (1990) 1.56
Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol (1990) 1.52
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol (1996) 1.52
Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol (1999) 1.49
Vaccinia-specific cytotoxic T-cell responses in the context of H-2 antigens not encountered in thymus may reflect aberrant recognition of a virus-H-2 complex. J Exp Med (1979) 1.48
Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology (1988) 1.47
Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol (2000) 1.47
Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J Immunol (1993) 1.46
Different effector cell types in antibody-dependent cell-mediated cytotoxicity. Nature (1975) 1.45
Specific and non-specific immunity to haemoprotozoa. Am J Trop Med Hyg (1977) 1.43
Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol (1994) 1.43
Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium. J Virol (1996) 1.42
Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol (1999) 1.41
Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci U S A (2001) 1.39
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39